NAMENDA XR

Drug Allergan Inc.
Total Payments
$35,765
Transactions
688
Doctors
480
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2018 $2.32 1 1
2017 $35,762 687 479

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $35,035 433 98.0%
Education $730.10 255 2.0%

Top Doctors Receiving Payments for NAMENDA XR — Page 20

Doctor Specialty Location Total Records
, M.D Neurology San Luis Obispo, CA $2.75 1
, MD Internal Medicine Solvang, CA $2.75 1
, D.O Surgery Saginaw, MI $2.75 1
, M.D Health Winston-Salem, NC $2.56 1
, M.D., D.O Family Medicine Bronx, NY $2.32 1
, MD Family Medicine Ellsworth, KS $1.81 1
«1…181920

Manufacturing Companies

Product Information

  • Type Drug
  • Total Payments $35,765
  • Total Doctors 480
  • Transactions 688

About NAMENDA XR

NAMENDA XR is a drug associated with $35,765 in payments to 480 healthcare providers, recorded across 688 transactions in the CMS Open Payments database. The primary manufacturer is Allergan Inc..

Payment data is available from 2017 to 2018. In 2018, $2.32 was paid across 1 transactions to 1 doctors.

The most common payment nature for NAMENDA XR is "Food and Beverage" ($35,035, 98.0% of total).